A medical bioinformatics approach for metabolic disorders: Biomedical data prediction, modeling, and systematic analysis
Chen M, Hofestädt R (2006)
JOURNAL OF BIOMEDICAL INFORMATICS 39(2): 147-159.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Chen, M;
Hofestädt, RalfUniBi
Einrichtung
Abstract / Bemerkung
During the past century, studies of metabolic disorders have focused research efforts to improve clinical diagnosis and management, to illuminate metabolic mechanisms, and to find effective treatments. The availability of human genome sequences and trallscriptomic, proteomic, and metabolomic data provides us with a challenging opportunity to develop computational approaches for systematic analysis of metabolic disorders. In this paper, we present a strategy of bioinformatics analysis to exploit the current data available both on genomic and metabolic levels and integrate these at novel levels of understanding of metabolic disorders. PathAligner is applied to predict biomedical data based on a given disorder. A case study on urea cycle disorders is demonstrated. A Petri net model is constructed to estimate the regulation both on genomic and metabolic levels. We also analyze the transcription factors, signaling pathways and associated disorders to interpret the occurrence and regulation of the urea cycle. Availability. PathAligner's metabolic disorder analyzer is available at http://bibiserv.techfak.uni-bielefeld.de/pathaligner/pathaligner_MDA.htm l. Supplementary materials are available at http://www.techflk.ulli-bielefeld.de/-mchen/metabolic-disorders. (c) 2005 Elsevier Inc. All rights reserved.
Stichworte
systems biology;
integrative bioinformatics;
urea cycle disorders;
inborn errors;
PathAligner;
metabolic disorders;
medical bioinformatics
Erscheinungsjahr
2006
Zeitschriftentitel
JOURNAL OF BIOMEDICAL INFORMATICS
Band
39
Ausgabe
2
Seite(n)
147-159
ISSN
1532-0464
Page URI
https://pub.uni-bielefeld.de/record/1599808
Zitieren
Chen M, Hofestädt R. A medical bioinformatics approach for metabolic disorders: Biomedical data prediction, modeling, and systematic analysis. JOURNAL OF BIOMEDICAL INFORMATICS. 2006;39(2):147-159.
Chen, M., & Hofestädt, R. (2006). A medical bioinformatics approach for metabolic disorders: Biomedical data prediction, modeling, and systematic analysis. JOURNAL OF BIOMEDICAL INFORMATICS, 39(2), 147-159. https://doi.org/10.1016/j.jbi.2005.05.005
Chen, M, and Hofestädt, Ralf. 2006. “A medical bioinformatics approach for metabolic disorders: Biomedical data prediction, modeling, and systematic analysis”. JOURNAL OF BIOMEDICAL INFORMATICS 39 (2): 147-159.
Chen, M., and Hofestädt, R. (2006). A medical bioinformatics approach for metabolic disorders: Biomedical data prediction, modeling, and systematic analysis. JOURNAL OF BIOMEDICAL INFORMATICS 39, 147-159.
Chen, M., & Hofestädt, R., 2006. A medical bioinformatics approach for metabolic disorders: Biomedical data prediction, modeling, and systematic analysis. JOURNAL OF BIOMEDICAL INFORMATICS, 39(2), p 147-159.
M. Chen and R. Hofestädt, “A medical bioinformatics approach for metabolic disorders: Biomedical data prediction, modeling, and systematic analysis”, JOURNAL OF BIOMEDICAL INFORMATICS, vol. 39, 2006, pp. 147-159.
Chen, M., Hofestädt, R.: A medical bioinformatics approach for metabolic disorders: Biomedical data prediction, modeling, and systematic analysis. JOURNAL OF BIOMEDICAL INFORMATICS. 39, 147-159 (2006).
Chen, M, and Hofestädt, Ralf. “A medical bioinformatics approach for metabolic disorders: Biomedical data prediction, modeling, and systematic analysis”. JOURNAL OF BIOMEDICAL INFORMATICS 39.2 (2006): 147-159.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
9 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Mathematical analysis predicts imbalanced IDH1/2 expression associates with 2-HG-inactivating β-oxygenation pathway in colorectal cancer.
Koseki J, Colvin H, Fukusumi T, Nishida N, Konno M, Kawamoto K, Tsunekuni K, Matsui H, Doki Y, Mori M, Ishii H., Int J Oncol 46(3), 2015
PMID: 25586680
Koseki J, Colvin H, Fukusumi T, Nishida N, Konno M, Kawamoto K, Tsunekuni K, Matsui H, Doki Y, Mori M, Ishii H., Int J Oncol 46(3), 2015
PMID: 25586680
1H NMR-based metabonomic study on the metabolic changes in the plasma of patients with functional dyspepsia and the effect of acupuncture.
Wu Q, Zhang Q, Sun B, Yan X, Tang Y, Qiao X, Chen Q, Yu S, Liang F., J Pharm Biomed Anal 51(3), 2010
PMID: 19854601
Wu Q, Zhang Q, Sun B, Yan X, Tang Y, Qiao X, Chen Q, Yu S, Liang F., J Pharm Biomed Anal 51(3), 2010
PMID: 19854601
Platelet linoleic acid is a potential biomarker of advanced non-small cell lung cancer.
de Castro J, Rodríguez MC, Martínez-Zorzano VS, Llanillo M, Sánchez-Yagüe J., Exp Mol Pathol 87(3), 2009
PMID: 19733167
de Castro J, Rodríguez MC, Martínez-Zorzano VS, Llanillo M, Sánchez-Yagüe J., Exp Mol Pathol 87(3), 2009
PMID: 19733167
Petri net modelling of gene regulation of the Duchenne muscular dystrophy.
Grunwald S, Speer A, Ackermann J, Koch I., Biosystems 92(2), 2008
PMID: 18372101
Grunwald S, Speer A, Ackermann J, Koch I., Biosystems 92(2), 2008
PMID: 18372101
Erythrocyte and platelet phospholipid fatty acids as markers of advanced non-small cell lung cancer: comparison with serum levels of sialic acid, TPS and Cyfra 21-1.
de Castro J, Rodríguez MC, Martínez-Zorzano VS, Hernández-Hernández A, Llanillo M, Sánchez-Yagüe J., Cancer Invest 26(4), 2008
PMID: 18443962
de Castro J, Rodríguez MC, Martínez-Zorzano VS, Hernández-Hernández A, Llanillo M, Sánchez-Yagüe J., Cancer Invest 26(4), 2008
PMID: 18443962
Computational systems biology in drug discovery and development: methods and applications.
Materi W, Wishart DS., Drug Discov Today 12(7-8), 2007
PMID: 17395089
Materi W, Wishart DS., Drug Discov Today 12(7-8), 2007
PMID: 17395089
Computational systems biology in cancer: modeling methods and applications.
Materi W, Wishart DS., Gene Regul Syst Bio 1(), 2007
PMID: 19936081
Materi W, Wishart DS., Gene Regul Syst Bio 1(), 2007
PMID: 19936081
Systems biology, metabolic modelling and metabolomics in drug discovery and development.
Kell DB., Drug Discov Today 11(23-24), 2006
PMID: 17129827
Kell DB., Drug Discov Today 11(23-24), 2006
PMID: 17129827
Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS-LDA.
Yi LZ, He J, Liang YZ, Yuan DL, Chau FT., FEBS Lett 580(30), 2006
PMID: 17141227
Yi LZ, He J, Liang YZ, Yuan DL, Chau FT., FEBS Lett 580(30), 2006
PMID: 17141227
44 References
Daten bereitgestellt von Europe PubMed Central.
AUTHOR UNKNOWN, 0
Clarke, 1996
Glanze, 1986
Polyglutamine aggregates in SCA6 Purkinje cells: a tail of two toxicities.
Gomez CM., Neurology 56(12), 2001
PMID: 11425924
Gomez CM., Neurology 56(12), 2001
PMID: 11425924
Heterogeneous database integration in biomedicine.
Sujansky W., J Biomed Inform 34(4), 2001
PMID: 11977810
Sujansky W., J Biomed Inform 34(4), 2001
PMID: 11977810
A model for data integration systems of biomedical data applied to online genetic databases
Mork, J Biomed Inform 35(Suppl.), 2001
Mork, J Biomed Inform 35(Suppl.), 2001
Web-based information retrieval system for the prediction of metabolic pathways.
Chen M, Hofestadt R., IEEE Trans Nanobioscience 3(3), 2004
PMID: 15473071
Chen M, Hofestadt R., IEEE Trans Nanobioscience 3(3), 2004
PMID: 15473071
AUTHOR UNKNOWN, 0
A modeling tool for biomedical systems
Thomaseth, Simulation Pract Theory 9(1–2), 2001
Thomaseth, Simulation Pract Theory 9(1–2), 2001
Peterson, 1981
AUTHOR UNKNOWN, 0
Hofestaedt, Quantitative modeling of biochemical networks. In silico Biol 1(), 1998
AUTHOR UNKNOWN, 0
Executable Petri net models for the analysis of metabolic pathways
Genrich, Intl. J. STTT 3(), 2001
Genrich, Intl. J. STTT 3(), 2001
Quantitative Petri net model of gene regulated metabolic networks in the cell.
Chen M, Hofestadt R., In Silico Biol. (Gedrukt) 3(3), 2003
PMID: 12954095
Chen M, Hofestadt R., In Silico Biol. (Gedrukt) 3(3), 2003
PMID: 12954095
Model validation of biological pathways using Petri nets--demonstrated for apoptosis.
Heiner M, Koch I, Will J., BioSystems 75(1-3), 2004
PMID: 15245801
Heiner M, Koch I, Will J., BioSystems 75(1-3), 2004
PMID: 15245801
Constructing biological pathway models with hybrid functional Petri nets
Doi, In Silico Biol 4(2), 2004
Doi, In Silico Biol 4(2), 2004
AUTHOR UNKNOWN, 0
AUTHOR UNKNOWN, 0
AUTHOR UNKNOWN, 0
AUTHOR UNKNOWN, 0
AUTHOR UNKNOWN, 0
Medical diagnostic system using fuzzy coloured Petri nets under uncertainty
Ouchi, Medinfo 9(1), 1998
Ouchi, Medinfo 9(1), 1998
[Structural description of the human eye using Petri nets]
Gerhard E, Wippich K., Biomed Tech (Berl) 36(4), 1991
PMID: 1854904
Gerhard E, Wippich K., Biomed Tech (Berl) 36(4), 1991
PMID: 1854904
Qualitative modeling of normal blood coagulation and its pathological states using stochastic activity networks.
Mounts WM, Liebman MN., Int. J. Biol. Macromol. 20(4), 1997
PMID: 9253647
Mounts WM, Liebman MN., Int. J. Biol. Macromol. 20(4), 1997
PMID: 9253647
Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors.
Ye X, Robinson MB, Batshaw ML, Furth EE, Smith I, Wilson JM., J. Biol. Chem. 271(7), 1996
PMID: 8631974
Ye X, Robinson MB, Batshaw ML, Furth EE, Smith I, Wilson JM., J. Biol. Chem. 271(7), 1996
PMID: 8631974
Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
Ye X, Robinson MB, Pabin C, Batshaw ML, Wilson JM., Gene Ther. 7(20), 2000
PMID: 11083498
Ye X, Robinson MB, Pabin C, Batshaw ML, Wilson JM., Gene Ther. 7(20), 2000
PMID: 11083498
BioLayout--an automatic graph layout algorithm for similarity visualization.
Enright AJ, Ouzounis CA., Bioinformatics 17(9), 2001
PMID: 11590107
Enright AJ, Ouzounis CA., Bioinformatics 17(9), 2001
PMID: 11590107
From topology to dynamics in biochemical networks.
Fox JJ, Hill CC., Chaos 11(4), 2001
PMID: 12779520
Fox JJ, Hill CC., Chaos 11(4), 2001
PMID: 12779520
The small world inside large metabolic networks.
Wagner A, Fell DA., Proc. Biol. Sci. 268(1478), 2001
PMID: 11522199
Wagner A, Fell DA., Proc. Biol. Sci. 268(1478), 2001
PMID: 11522199
Extreme self-organization in networks constructed from gene expression data.
Agrawal H., Phys. Rev. Lett. 89(26), 2002
PMID: 12484863
Agrawal H., Phys. Rev. Lett. 89(26), 2002
PMID: 12484863
A duplication growth model of gene expression networks.
Bhan A, Galas DJ, Dewey TG., Bioinformatics 18(11), 2002
PMID: 12424120
Bhan A, Galas DJ, Dewey TG., Bioinformatics 18(11), 2002
PMID: 12424120
Birth and death of protein domains: a simple model of evolution explains power law behavior.
Karev GP, Wolf YI, Rzhetsky AY, Berezovskaya FS, Koonin EV., BMC Evol. Biol. 2(), 2002
PMID: 12379152
Karev GP, Wolf YI, Rzhetsky AY, Berezovskaya FS, Koonin EV., BMC Evol. Biol. 2(), 2002
PMID: 12379152
Hierarchical organization of modularity in metabolic networks.
Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL., Science 297(5586), 2002
PMID: 12202830
Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL., Science 297(5586), 2002
PMID: 12202830
Reconstruction of metabolic networks from genome data and analysis of their global structure for various organisms.
Ma H, Zeng AP., Bioinformatics 19(2), 2003
PMID: 12538249
Ma H, Zeng AP., Bioinformatics 19(2), 2003
PMID: 12538249
Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren syndrome.
Nissinen R, Paimela L, Julkunen H, Tienari PJ, Leirisalo-Repo M, Palosuo T, Vaarala O., Scand. J. Rheumatol. 32(6), 2003
PMID: 15080264
Nissinen R, Paimela L, Julkunen H, Tienari PJ, Leirisalo-Repo M, Palosuo T, Vaarala O., Scand. J. Rheumatol. 32(6), 2003
PMID: 15080264
Altered immunoglobulin metabolism in systemic lupus erythematosus and heumatoid arthritis.
Levy J, Barnett EV, MacDonald NS, Klinenberg JR., J. Clin. Invest. 49(4), 1970
PMID: 5309797
Levy J, Barnett EV, MacDonald NS, Klinenberg JR., J. Clin. Invest. 49(4), 1970
PMID: 5309797
Restricted immunoglobulin variable region gene usage by hybridoma rheumatoid factors from patients with systemic lupus erythematosus and rheumatoid arthritis.
Newkirk MM, Rauch J, Mageed RA, Jefferis R, Posnett DN, Silverman GJ., Mol. Immunol. 30(3), 1993
PMID: 7679467
Newkirk MM, Rauch J, Mageed RA, Jefferis R, Posnett DN, Silverman GJ., Mol. Immunol. 30(3), 1993
PMID: 7679467
Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters. SLE study group.
Witte T, Hartung K, Sachse C, Matthias T, Fricke M, Kalden JR, Lakomek HJ, Peter HH, Schmidt RE., Rheumatol. Int. 19(3), 2000
PMID: 10776689
Witte T, Hartung K, Sachse C, Matthias T, Fricke M, Kalden JR, Lakomek HJ, Peter HH, Schmidt RE., Rheumatol. Int. 19(3), 2000
PMID: 10776689
Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis.
Carlson E, Rothfield N., Arthritis Rheum. 48(4), 2003
PMID: 12687569
Carlson E, Rothfield N., Arthritis Rheum. 48(4), 2003
PMID: 12687569
Association between the expression of inducible nitric oxide synthase by chondrocytes and its nitric oxide-generating activity in adjuvant arthritis in rats.
Yonekura Y, Koshiishi I, Yamada K, Mori A, Uchida S, Nakamura T, Utsumi H., Nitric Oxide 8(3), 2003
PMID: 12826065
Yonekura Y, Koshiishi I, Yamada K, Mori A, Uchida S, Nakamura T, Utsumi H., Nitric Oxide 8(3), 2003
PMID: 12826065
Calorie restricted diet and urinary pentosidine in patients with rheumatoid arthritis.
Iwashige K, Kouda K, Kouda M, Horiuchi K, Takahashi M, Nagano A, Tanaka T, Takeuchi H., J Physiol Anthropol Appl Human Sci 23(1), 2004
PMID: 14757997
Iwashige K, Kouda K, Kouda M, Horiuchi K, Takahashi M, Nagano A, Tanaka T, Takeuchi H., J Physiol Anthropol Appl Human Sci 23(1), 2004
PMID: 14757997
Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.
Batshaw ML, Brusilow S, Waber L, Blom W, Brubakk AM, Burton BK, Cann HM, Kerr D, Mamunes P, Matalon R, Myerberg D, Schafer IA., N. Engl. J. Med. 306(23), 1982
PMID: 7078580
Batshaw ML, Brusilow S, Waber L, Blom W, Brubakk AM, Burton BK, Cann HM, Kerr D, Mamunes P, Matalon R, Myerberg D, Schafer IA., N. Engl. J. Med. 306(23), 1982
PMID: 7078580
Alternative pathway therapy for urea cycle disorders: twenty years later.
Batshaw ML, MacArthur RB, Tuchman M., J. Pediatr. 138(1 Suppl), 2001
PMID: 11148549
Batshaw ML, MacArthur RB, Tuchman M., J. Pediatr. 138(1 Suppl), 2001
PMID: 11148549
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 16023895
PubMed | Europe PMC
Suchen in
Google Scholar